PROTAC EGFR degrader 7

Product Description: PROTAC EGFR degrader 7 (compound 13b) is a potent and selective CRBN-recruiting PROTAC EGFRL858R/T790M degrader, with a DC50 of 13.2 nM. PROTAC EGFR degrader 7 inhibits NCI–H1975 cells proliferation, with an IC50 of 46.82 nM. PROTAC EGFR degrader 7 significantly induces apoptosis and G2/M phase arrest in NCI–H1975 cell. PROTAC EGFR degrader 7 shows antitumor activity, and can be used for non-small cell lung cancer (NSCLC) research[1]. PROTAC EGFR degrader 7 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

Applications: Cancer-Kinase/protease

Formula: C46H48N10O6

References: [1]Zhang W, et al. Discovery of highly potent and selective CRBN-recruiting EGFRL858R/T790M degraders in vivo. Eur J Med Chem. 2022 Aug 5;238:114509.

Molecular Weight: 836.94

Compound Purity: 99.99

Research Area: Cancer

Solubility: DMSO : 120 mg/mL (ultrasonic)

Target: Apoptosis;EGFR;PROTACs

• Artikelnummer: MEXHY-147858-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-147858-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK